Barclays Target Cut, Still a Hold

Tags: bcs
20 Nov 2:20am
Read original blog entry

We are maintaining our Hold on Barclays PLC (BCS), but cutting our target price to $9.25. In its third quarter trading update, Barclays noted that profit before tax for the 2008's first nine months was slightly ahead of 2007. Revenue growth was strong, and costs grew broadly in line with the rate of income growth.

Impairment charges grew at a similar rate to the first half of 2008. Barclays announced £7.3 billion of new capital, including £3 billion of reserve capital instruments, with an associated issue of warrants, and £4.3 billion of mandatorily convertible notes.

We are reducing our EPADS estimates to $3.22 from $3.80 for 2008 and to $2.08 from $4.20 for 2009, mainly due to dilution caused from the capital raising and appreciation of the $ against the £. We expect results to reflect global markets turmoil, economic weakening, and the recent $1.75 billion acquisition of Lehman Brothers North American operations. Barclays eliminated its final dividend for 2008.

Read the full analyst report on BCS.



Get real-time market insights and profitable stock recommendations from the team of analysts at Zacks Equity Research. See all today’s Analyst Blog entries on Zacks.com.

Comments

Back to top

Post comment

Back to top

Post a comment

Please login to post a comment

About

ZacksResearch

Zacks Investment Research is one of the most highly regarded firms in the investment industry. Our firm has long believed that that quantitative models (like the Zacks Rank) can predict stock prices more accurately than individual analysts. However we also recognize that models are most effective when they are employed by analysts who have deep fundamental knowledge of the company and its industry. Consequently Zacks Equity Research combines Zacks quantitative models with the insight provided by an experienced team of 50 analysts to create superior long term stock recommendations. Discover all their timely insight and recommendations daily on Zacks.com.